Related Experiment Video
Updated: Apr 19, 2026
Preparation of Pooled Human Platelet Lysate pHPL as an Efficient Supplement for Animal Serum-Free Human Stem Cell Cultures
Published on: October 30, 2009
Plasmapheresis: Lifesaving treatment in severe cases of HELLP syndrome
Jamshid Vafaeimanesh1, Azam Nazari2, Fatemeh Hosseinzadeh1
1Clinical Research Development Center, Qom University of Medical Sciences, Qom, Iran.
Background:
HELLP syndrome is an important complications in pregnancy which increases maternal and fetal mortality. This disease usually remits with supportive treatment which includes prescription of corticosteroid, magnesium sulfate, stabilization of mother and pregnancy termination. Plasmapheresis is a treatment of choice which improves clinical outcomes in complicated cases.
Case Presentation:
A 22-year-old woman with coagulopathy and respiratory distress and 33-year-old woman with a history of cerebellar medulloblastoma at 32-weeks' gestation developed thrombocytopenia due to HELLP syndrome were treated with plasmapheresis were described.
Conclusion:
Plasmapheresis can significantly improve the outcome of patients with HELLP syndrome who are unresponsive to conservative therapy.
Related Concept Videos
01:25Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
01:30Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis